Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
about
Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis BMR Elastography of Liver Disease: State of the Art.Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers.Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems.Evaluation of the patient with hepatitis BAn intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers.A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.Comparison of noninvasive models of fibrosis in chronic hepatitis B.Liver stiffness measurement-based scoring system for significant inflammation related to chronic hepatitis BHBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis BRed blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B.Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections.Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B.Evaluation and treatment of the patient coinfected with hepatitis B and HIV.A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model.Assessment of fibrosis in chronic liver diseases.Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.Liver biopsy findings in chronic hepatitis B.Parameters associated with significant liver histological changes in patients with chronic hepatitis B.Noninvasive scoring system for significant inflammation related to chronic hepatitis B.Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parametersBiomarkers of liver fibrosis.Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy.Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery.Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B.Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal.Noninvasive predictive models of liver fibrosis in patients with chronic hepatitis B.A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection.Hepatitis virus infection and age-related cataractCorrelation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein.
P2860
Q26740195-767E5A59-0948-4BCF-AA12-E37CC51BB852Q28741501-07A601E0-1F36-46CB-A7AC-001B0D7408C8Q30403258-80C793A0-8620-4A6B-A4EA-43616F25F859Q30467234-323457CF-F5A8-4E15-B72E-BE40B883CEF3Q33671532-7F4C2BCF-7474-4593-A28C-BA659BEBE5EAQ33787655-F8B9DD3C-D51A-4688-9B04-3C82783B763FQ33871707-584EDA94-0DE2-4FE2-B9F2-C4323F4B4883Q33896660-3D679536-44A8-449B-8B15-FAC04136258FQ33968189-1E6CB2A7-4A29-4FAD-9B6E-C6A3E02B950FQ34184642-7812877C-2089-41FF-9AD6-1176ED17CA7AQ34199677-08F041EA-6AA5-49B3-B739-D25B90233368Q34435273-164882F5-CDAA-4F79-A3D9-BE3A8B40C5E2Q34998266-CE5579C9-FC0D-4A5A-8063-6876FCB5C709Q35594244-0837566F-9101-42A0-9E45-A41098EAD5A6Q35772764-918A6079-3FDC-4382-8826-C664DC87FFFFQ35879457-07239BC9-4046-4B7C-AF9C-55F07D59EB94Q36151026-28CA7F71-119E-41BE-999E-D5915863A3F4Q36875021-F8674FA5-10D9-4F9E-849F-99B479E703F3Q37017919-EF03EDD9-87BD-4DB3-9357-66E1D84024A9Q37157397-254C896C-E690-45FE-A320-097C3013A3E0Q37216879-58EE2BC9-69B2-4C97-A607-65624197E70FQ37387494-C67FF944-954D-4645-B055-4BFB87704F64Q37399469-7E6B99C5-EFBB-4955-84A6-6C771F6CFCA7Q37404895-8E20B3D4-2293-4A6D-895A-EEE7BC5AFD4CQ37462537-DBFBCF83-A623-43AD-AD90-9CFCE7B3C3B5Q37590449-E3CD026F-02A8-4D75-8E7D-759757B5AC98Q37692297-4E30BC71-1BB8-415E-B880-B9DA940D3B26Q37707436-D64B36FA-620B-4C3A-A192-375203BB0EA8Q37825547-0F80A194-E324-4FAD-80BC-9A022180A940Q38915082-58B847B6-1582-428F-B9BC-83E0DC21B150Q39735958-B1A38B30-CC5F-430B-8EC6-4472AD30A3E1Q40062007-A791D766-B87A-4793-BB19-40E0577F5052Q40122998-5AC711B2-2358-4DB0-8AED-0D00B6C9B0C1Q40355176-9B9E0504-BC5D-4E5C-B28C-151BB3292F36Q40678115-9364E25F-BAE9-4009-B89F-BF2CC4CB39B0Q40743810-75FF7EEA-527E-4F98-9B14-7753C300D0F8Q41416623-F1EC0AB1-0C08-4432-B223-A0E2F88743DDQ42254850-8375B594-864D-49D8-ABFA-8A3CE1523630Q42375958-7A707CE3-F4F5-4275-AF56-07FACC918023Q43014834-B289C116-AF4A-46EB-B66E-BEECC3CBE9CD
P2860
Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Noninvasive markers of liver f ...... B-virus related liver disease.
@en
Noninvasive markers of liver f ...... B-virus related liver disease.
@nl
type
label
Noninvasive markers of liver f ...... B-virus related liver disease.
@en
Noninvasive markers of liver f ...... B-virus related liver disease.
@nl
prefLabel
Noninvasive markers of liver f ...... B-virus related liver disease.
@en
Noninvasive markers of liver f ...... B-virus related liver disease.
@nl
P2093
P50
P1476
Noninvasive markers of liver f ...... B-virus related liver disease.
@en
P2093
Abolfazl Najjari
Arezoo Estakhri
Ashraf Mohamadkhani
Atoosa Fazlollahi
Farhad Ghoujeghi
Ghodrat Montazeri
Hossein Nobakht
Jafar Nasiri
Mohammad Hossein Forouzanfar
Negin Nouri
P304
P356
10.1111/J.1572-0241.2006.00788.X
P407
P577
2006-10-04T00:00:00Z